Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results , with sales up 6.6% year on year to $657.3 million. The company expects the full year’s revenue to be around $2.68 ...

Learn more about whether Glaukos Corporation or Globus Medical, Inc. is a better investment based on AAII's A+ Investor ...

Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve ...

Learn more about whether Globus Medical, Inc. or Inspire Medical Systems, Inc. is a better investment based on AAII's A+ ...

AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and ...

Globus Medical, Inc. GMED reported fourth-quarter 2024 adjusted earnings per share (EPS) of 84 cents, which beat the Zacks Consensus Estimate by 10.5%. The figure increased 40% year over year.

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & ...

Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...

Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations , with sales up 6.6% year on year to $657.3 million. The company expects the ...